Improved Arterial Compliance by a Novel Advanced Glycation End-Product Crosslink Breaker

Ovid Technologies (Wolters Kluwer Health) - Tập 104 Số 13 - Trang 1464-1470 - 2001
David A. Kass1, Edward P. Shapiro1, Miho Kawaguchi1, Anne Capriotti1, Angelo Scuteri1, Robert C. deGroof1, Edward G. Lakatta1
1From the Division of Cardiology, The Johns Hopkins Medical Institutions, Baltimore, Md (D.A.K., E.P.S., M.K., A.R.C.); the Gerontology Research Center, National Institute on Aging, Baltimore, Md (A.S., E.G.L.); and Alteon Inc, Ramsey, NJ (R.C.D.). A. Scuteri is currently located at the INRCA, Rome, Italy.

Tóm tắt

Background Arterial stiffening with increased pulse pressure is a leading risk factor for cardiovascular disease in the elderly. We tested whether ALT-711, a novel nonenzymatic breaker of advanced glycation end-product crosslinks, selectively improves arterial compliance and lowers pulse pressure in older individuals with vascular stiffening. Methods and Results Nine US centers recruited and randomly assigned subjects with resting arterial pulse pressures >60 mm Hg and systolic pressures >140 mm Hg to once-daily ALT-711 (210 mg; n=62) or placebo (n=31) for 56 days. Preexisting antihypertensive treatment (90% of subjects) was continued during the study. Morning upright blood pressure, stroke volume, cardiac output, systemic vascular resistance, total arterial compliance, carotid-femoral pulse wave velocity, and drug tolerability were assessed. ALT-711 netted a greater decline in pulse pressures than placebo (−5.3 versus −0.6 mm Hg at day 56; P =0.034 for treatment effect by repeated-measures ANOVA). Systolic pressure declined in both groups, but diastolic pressure fell less with ALT-711 ( P =0.056). Mean pressure declined similarly in both groups (−4 mm Hg; P <0.01 for each group, P =0.34 for treatment effect). Total arterial compliance rose 15% in ALT-711–treated subjects versus no change with placebo ( P =0.015 versus ALT-711), an effect that did not depend on reduced mean pressure. Pulse wave velocity declined 8% with ALT-711 ( P <0.05 at day 56, P =0.08 for treatment effect). Systemic arterial resistance, cardiac output, and heart rate did not significantly change in either group. Conclusions ALT-711 improves total arterial compliance in aged humans with vascular stiffening, and it may provide a novel therapeutic approach for this abnormality, which occurs with aging, diabetes, and isolated systolic hypertension.

Từ khóa


Tài liệu tham khảo

Nichols WW O’Rourke MF. Aging. In: Nichols WW O’Rourke MF eds. McDonald’s Blood Flow in Arteries. London: Edward Arnold; 1998: 398–420.

10.1161/hyp.33.6.1392

10.1038/sj.jhh.1001023

10.1161/hyp.36.4.489

10.1016/S0735-1097(01)01108-1

10.1016/S0895-7061(00)01232-2

10.1161/circ.100.4.354

10.1001/jama.281.7.634

10.1001/archinte.160.8.1085

10.1161/circ.103.9.1245

10.1001/archinte.160.18.2765

10.1016/S0735-1097(00)00687-2

Safar ME. Epidemiological findings imply that goals for drug treatment of hypertension need to be revised. Circulation. 2001; 103: 1088–1089.

10.1097/00004872-200018110-00001

10.1007/s11906-000-0008-0

10.1023/A:1007856014581

10.1097/00004872-200018090-00001

10.1111/j.1749-6632.1992.tb38649.x

10.1093/cvr/27.6.942

10.1073/pnas.95.8.4630

10.1073/pnas.95.3.1301

10.1073/pnas.040558497

10.1073/pnas.98.3.1171

10.1038/382275a0

10.1161/circ.95.7.1827

10.1109/10.764946

Nichols W O’Rourke M. Contours of pressure and flow waves in arteries. In: Nichols WW O’Rourke MF eds. McDonald’s Blood Flow in Arteries. London: Edward Arnold; 1998: 180–185.

10.1161/01.hyp.14.2.129

10.1152/ajpcell.1998.274.2.C500

10.1016/S0735-1097(01)01362-6

10.1080/080370500300000914

Goonasekera CD, Dillon MJ. Random zero sphygomomanometer versus automatic oscillometric blood pressure monitor; is either the instrument of choice? J Hum Hypertens. 1995; 9: 885–889.

10.1161/hyp.36.4.484

10.1152/ajpheart.1999.276.2.H424

10.1161/res.71.3.1386792

10.1016/0002-9149(87)90993-3

10.1038/sj.jhh.1000780

Kahonen M, Ylitalo R, Koobi T, et al. Influence of captopril, propranolol, and verapamil on arterial pulse wave velocity and other cardiovascular parameters in healthy volunteers. Int J Clin Pharmacol Ther. 1998; 36: 483–489.

10.1161/circ.102.11.1270

Thông tin
Thông tin xuất bản

Ovid Technologies (Wolters Kluwer Health)

Tập 104 Số 13

1464-1470

Thông tin tác giả